Start
Features
Free trial / FAQ

Researchers
Physicians
Pharmacists
Ecotrophologists
Product Managers
in Health Industries

Loading…

Medical Research Finder

Legal Notice
Privacy
Terms of Use

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

meRfi® AI Chat

Anti-PD-L1 Antibodies / PD-L1 Inhibitors & Non-small-cell lung cancer (NSCLC)

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

(Login)

Navigation

Immune checkpoint inhibitors (ICIs)-based treatments are being increasingly adopted into clinical practice and were associated with better outcomes versus chemotherapy.
Zhang et al. 2021w Immunotherapy 13(18): 1521-1533

…

References (Sources)

Cancer immunotherapy
Gajewski & Schumacher 2013 Curr Opin Immunol. 25(2): 259-60
Molecular Determinants of Response to Anti-Programmed Cell Death (PD)-1 and Anti-Programmed Death-Ligand 1 (PD-L1) Blockade in Patients With Non-Small-Cell Lung Cancer Profiled With Targeted Next-Generation Sequencing
Rizvi et al. 2018 JCO 36: 633-641
Real-world treatment patterns and outcomes in PD-L1-positive non-small cell lung cancer
Zhang et al. 2021w Immunotherapy 13(18): 1521-1533
The efficacy of PD-1/PD-L1 inhibitors in advanced squamous-cell lung cancer: a meta-analysis of 3112 patients
Chen et al. 2019i
Meta-Analysis
The TLR4/ERK/PD-L1 axis may contribute to NSCLC initiation
Kang et al. 2020

AI Chat

7/2/2026

Chat with our artificial intelligence:

Start chat!

Anti-PD-L1 Antibodies / PD-L1 Inhibitors & Non-small-cell lung cancer (NSCLC)

Welcome to meRfi Microbiome!

Navigation

Contents

References (Sources)

AI Chat